Johnson M R, Abbas A, Norman-Taylor J Q, Riddle A F, Grudzinskas J G, Chard T, Nicolaides K H
Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London, UK.
Hum Reprod. 1993 Feb;8(2):323-6. doi: 10.1093/oxfordjournals.humrep.a138044.
Circulating placental protein 14 (PP14) levels were measured during the first trimester in three groups of pregnant women: (i) natural conception (n = 15); (ii) pituitary desensitization with buserelin and ovarian stimulation with human menopausal gonadotrophin (HMG) followed by in-vitro fertilization and embryo transfer (IVF-ET) (n = 15); and (iii) ovarian stimulation with clomiphene citrate and HMG, followed by IVF-ET (n = 16). A 7- to 8-fold increase in serum PP14 levels was observed in normal pregnancies between weeks 4 and 10. This increase was earlier and less marked in group (ii) and absent in group (iii). These findings support the concept that endometrial function is altered in pregnancies achieved following ovarian stimulation. Alternatively, if the ovary is an important source of PP14, then these data suggest that in contrast to ovarian synthesis of steroids and the peptide relaxin, ovarian stimulation results in an impairment of PP14 synthesis, and that this is most marked when clomiphene citrate has been used.
在孕早期,对三组孕妇测定了循环胎盘蛋白14(PP14)水平:(i)自然受孕组(n = 15);(ii)使用布舍瑞林进行垂体脱敏并用人绝经期促性腺激素(HMG)进行卵巢刺激,随后进行体外受精和胚胎移植(IVF-ET)组(n = 15);以及(iii)使用枸橼酸氯米芬和HMG进行卵巢刺激,随后进行IVF-ET组(n = 16)。在正常妊娠的第4至10周期间,观察到血清PP14水平增加了7至8倍。在第(ii)组中,这种增加出现得更早且不太明显,而在第(iii)组中则未出现。这些发现支持了这样一种观点,即卵巢刺激后受孕的妊娠中子宫内膜功能发生了改变。或者,如果卵巢是PP14的重要来源,那么这些数据表明,与卵巢合成类固醇和肽类松弛素不同,卵巢刺激会导致PP14合成受损,并且当使用枸橼酸氯米芬时这种情况最为明显。